Pharmaceuticals News and Research

RSS

Unraveling the mysteries of cell factories, courtesy of new algorithm

Living cell factories can manufacture custom drug compounds and biofuels using biological enzymes.

2 Sep 2022

Researchers work on DNA-delivered antibodies to stop COVID-19

A new COVID-19 antibody delivery approach has progressed to clinical trials, thanks to funding from the Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND).

11 Jul 2022

New bacterial tool improves drug production in bacterial cells

The prescription humans use to manage high blood pressure, discomfort, or memory loss may one day originate from modified bacteria, cultivated in a vat like a yogurt, offering more inexpensive, sustainable drug options than people now have.

11 Jul 2022

Environmental chemical pollution threatens biodiversity and ecosystems

Environmental chemical pollution threatens biodiversity. However, the complexity of this pollution remains insufficiently recognized by decision-makers - this is what international researchers led by Gabriel Sigmund from the University of Vienna and Ksenia Groh from the Swiss Federal Institute of Aquatic Science and Technology (Eawag) argue in the most recent issue of "Science".

20 Jun 2022

Robotic finger covered with living skin tissue can heal itself

Researchers from the University of Tokyo pool knowledge of robotics and tissue culturing to create a controllable robotic finger covered with living skin tissue.

20 Jun 2022

Researchers developed a weapon to combat drug-resistant malaria

As the efficiency of conventional antimalarial medications deteriorates, a novel approach to combating malaria that sees the disease turn against itself could provide a viable treatment for the hundreds of millions of people affected globally every year.

6 Jun 2022

$Access to the Rigaku’s Electron Diffraction Technology without the Capital Outlay$

Access to the Rigaku’s Electron Diffraction Technology without the Capital Outlay

With convenient and economical access to Rigaku’s state-of-the-art electron diffraction capabilities and applications experts, crystallization trials on samples smaller than 1 micron no longer need to delay your structural analysis programs.

From Rigaku Corporation 25 May 2022

New open-source tool automates RNA analysis, likely to encourage research and drug development

Scripps Research scientists have introduced a new software tool for examining RNA (ribonucleic acid) molecules, which play a variety of important roles in living things.

10 May 2022

Cryo-EM reveals the structure of fermentation enzyme phosphoketolase

Pharmaceuticals, plastics, and other industries use enzymes to help synthesize molecular feedstocks.

19 Apr 2022

Rigaku Pharma Forum 2022 for Advanced Analytical Solutions Used in Industry and Research

Rigaku is proud to be hosting the inaugural Pharma Forum, a free-to-attend, two-day virtual event from April 27-28, 2022. The forum examines a range of analytical techniques and how these can be applied during the development, formulation, and manufacture of pharmaceuticals.

From Rigaku Corporation 4 Apr 2022

How Important are Data Clouds to Life Sciences Research?

In this interview, we speak to Mike Tarselli, CSO of TetraScience, about their Tetra data cloud and the role it plays within scientific data analysis.

From TetraScience, Inc. 31 Mar 2022

CAR-T cell treatment via implantable biotechnology more effective in combating cancer

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

25 Mar 2022

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory

SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass.

From SEQENS 21 Mar 2022

Novel “green” synthesis of drug for inflammatory bowel disease

Steroids and antibody drugs are currently used to treat inflammatory bowel disease (IBD), which is characterized by chronic inflammation of the digestive tract.

16 Mar 2022

Genetic rat model shows robust Down syndrome features

In pursuit of better ways to test new therapies and further explore the impacts of the unique genetics associated with Down syndrome, researchers at Johns Hopkins Medicine and Tottori University in Japan have genetically engineered and characterized what is believed to be the first rat model of Down syndrome.

15 Mar 2022